Seconds-Resolved Measurements of Vancomycin Transport from the Plasma to the Interstitial Fluid Highlight a Path Towards Real-Time Therapeutic Drug Monitoring
Sensors · 04.04.2026 · 26 (7) · 2233
DOI: 10.3390/s26072233 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sensors, online erschienen am 04.04.2026. Verfasst von Julian Gerson und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychological and Brain Sciences, University of California, Santa Barbara, Santa Barbara, CA 93106, USA. Hauptthemen laut MEDLINE: Vancomycin, Extracellular Fluid, Drug Monitoring, Biosensing Techniques. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH Common Fund, National Institutes of Health, Office of Naval Research.
Abstract (Originalsprache)
Continuous, in vivo drug and biomarker measurements could transform healthcare, enabling both the high-precision personalization of drug dosing and the real-time monitoring of health status. A practical realization of this vision, however, requires an improved understanding of the relationship between concentrations measured in the easily accessible dermal interstitial fluid (ISF) that correlate with the plasma concentrations that guide clinical decision making. As a preliminary step towards this goal, here we have used electrochemical, aptamer-based (EAB) sensors to perform seconds-resolved vancomycin measurements in the plasma and subcutaneous ISF of live rats. Concentrations of the antibiotic in the ISF vary rather little between different subcutaneous sites and, after the very rapid initial distribution phase is complete, they are well correlated with the plasma concentrations (mean R2 = 0.88). Likewise, a simple, two-compartment, two-parameter model describes our six paired plasma and ISF drug time courses quantitatively. Together, these findings provide further evidence of the viability of the drug concentration measurements performed in the subcutaneous or dermal ISF as a less invasive approach to real-time drug monitoring in individual patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychological and Brain Sciences, University of California, Santa Barbara, Santa Barbara, CA 93106, USA.
- Neuroscience Research Institute, University of California, Santa Barbara, Santa Barbara, CA 93106, USA.
- Department of Bioengineering, University of California, Santa Barbara, Santa Barbara, CA 93106, USA.
- Department of Electrical and Computer Engineering, University of California, Santa Barbara, Santa Barbara, CA 93106, USA.
- Biomolecular Sciences and Engineering, University of California, Santa Barbara, Santa Barbara, CA 93106, USA.
- Department of Molecular Cellular and Developmental Biology, University of California, Santa Barbara, Santa Barbara, CA 93106, USA.
ORCID-Profile: Julian Gerson, Murat Kaan Erdal, Lisa C Fetter, Kaylyn K Leung, Joao Hespanha
Förderung
- NIH Common Fund
- National Institutes of Health
- Office of Naval Research
Zitieren
APA
Gerson, J., Erdal, M. K., Fetter, L. C., Leung, K. K., Emmons, N. A., Hespanha, J., Kirkpatrick, C. M., Plaxco, K. W., & Kippin, T. E. (2026). Seconds-Resolved Measurements of Vancomycin Transport from the Plasma to the Interstitial Fluid Highlight a Path Towards Real-Time Therapeutic Drug Monitoring. Sensors, 26(7), 2233. https://doi.org/10.3390/s26072233
Vancouver
Gerson J, Erdal MK, Fetter LC, Leung KK, Emmons NA, Hespanha J, et al. Seconds-Resolved Measurements of Vancomycin Transport from the Plasma to the Interstitial Fluid Highlight a Path Towards Real-Time Therapeutic Drug Monitoring. Sensors. 2026;26(7):2233. doi:10.3390/s26072233
BibTeX
@article{Gerson2026,
author = {Gerson, Julian and Erdal, Murat Kaan and Fetter, Lisa C and Leung, Kaylyn K and Emmons, Nicole A and Hespanha, Joao and Kirkpatrick, Carl M and Plaxco, Kevin W and Kippin, Tod E},
title = {Seconds-Resolved Measurements of Vancomycin Transport from the Plasma to the Interstitial Fluid Highlight a Path Towards Real-Time Therapeutic Drug Monitoring},
journal = {Sensors},
year = {2026},
volume = {26},
number = {7},
pages = {2233},
doi = {10.3390/s26072233}
}
EUVIMED